REGISTERED NUMBER: 09785389 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31 December 2024

for

Trident Pharma Properties Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTORS:

Dr K Swaminathan

Mrs U Swaminathan

REGISTERED OFFICE:

51 Shimbrooks

Great Leighs

Chelmsford

Essex

CM3 1SG

REGISTERED NUMBER:

09785389 (England and Wales)

ACCOUNTANTS:

Roches

Chartered Accountants

1 Manor Court

6 Barnes Wallis Road

Segensworth

Fareham

Hampshire

PO15 5TH

FIXED ASSETS

Investment property

4

498,000

501,000

CURRENT ASSETS

Debtors

5

592

550

CREDITORS

Amounts falling due within one year

6

385,313

381,306

NET CURRENT LIABILITIES

(384,721

)

(380,756

)

TOTAL ASSETS LESS CURRENT LIABILITIES

113,279

120,244

PROVISIONS FOR LIABILITIES

14,250

14,820

NET ASSETS

99,029

105,424

CAPITAL AND RESERVES

Called up share capital

2

2

Non-distributable reserves

7

79,486

80,296

Retained earnings

19,541

25,126

SHAREHOLDERS' FUNDS

99,029

105,424

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 4 April 2025 and were signed on its behalf by:

Dr K Swaminathan - Director

1.	STATUTORY INFORMATION

Trident Pharma Properties Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Investment property

Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Financial instruments

The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable and loans to related parties.

Financial assets & financial liabilities are initially recognised at the transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method. However, if the arrangement constitutes a financing transaction then it is measured at the present value of the future receipts discounted at a market rate of interest.

Financial assets & financial liabilities classified as receivable within one year are not amortised.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4.	INVESTMENT PROPERTY

Total

£

FAIR VALUE

At 1 January 2024

501,000

Revaluations

(1,000

)

Impairments

(2,000

)

At 31 December 2024

498,000

NET BOOK VALUE

At 31 December 2024

498,000

At 31 December 2023

501,000

Fair value at 31 December 2024 is represented by:

£

Valuation in 2020

47,105

Valuation in 2021

31,000

Valuation in 2022

29,000

Valuation in 2023

(14,000

)

Valuation in 2024

(3,000

)

Cost

407,895

498,000

The directors have assessed the fair value of the property based on the value of similar properties in the vicinity taking into account the condition of the property.

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.12.24

31.12.23

£

£

Trade debtors

-

168

Other debtors

592

382

592

550

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.12.24

31.12.23

£

£

Amounts owed to associates

381,257

375,969

Taxation and social security

712

2,588

Other creditors

3,344

2,749

385,313

381,306

7.

RESERVES

Non-distributable

reserves

£

At 1 January 2024

80,296

Fair value adjustment

(810

)

At 31 December 2024

79,486